Long-Term Outcome of Subjects With Elevated PSA in Healthy Taiwanese Men

Completed

• Conditions: Prostate Cancer

• Registration Number: NCT02088164
• Lead Sponsor: National Taiwan University Hospital

Brief Summary

To determine the long-term survival outcome of subjects who had various PSA levels at screening

Detailed Description

Not available

Study Timeline

• Study Start: 2012-02
• Primary Completion: 2012-04
• Study First Submitted: 2012-05-16
• Status Verified: 2014-03
• Study First Submitted QC: 2014-03-13
• Last Update Submitted: 2014-03-13
• Study First Posted: 2014-03-14
• Last Update Posted: 2014-03-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 27741

Inclusion Criteria

• Health men who received PSA screening at NTUH and CGMH

Exclusion Criteria

• Prior history of prostate cancer

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Diagnosis of prostate cancer	20 years (average)

Secondary Outcome Measures

Name	Time	Method
Cancer-specific death	20 years (average)
Overall survival	20 years (average)

Trial Locations

Locations (1)

National Taiwan University Hospital; 🇨🇳 Taipei city, Taiwan